Cargando…

Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein

Vaccines are central to controlling the coronavirus disease 2019 (COVID-19) pandemic but the durability of protection is limited for currently approved COVID-19 vaccines. Further, the emergence of variants of concern (VoCs) that evade immune recognition has reduced vaccine effectiveness, compounding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yeonsu, Jacobsen, Henning, Fuerholzner, Bettina, Eschke, Kathrin, Hoffmann, Markus, Chaudhry, M.Zeeshan, Bertoglio, Federico, Hust, Michael, Widera, Marek, Ciesek, Sandra, Pöhlmann, Stefan, Čičin-Šain, Luka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727759/ https://www.ncbi.nlm.nih.gov/pubmed/36482969 http://dx.doi.org/10.1101/2022.11.25.517953

Ejemplares similares

MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination
por: Kim, Yeonsu, et al.
Publicado: (2022)

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2022)

ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein
por: Ballmann, Rico, et al.
Publicado: (2022)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
por: Katzmarzyk, Maeva, et al.
Publicado: (2023)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
por: Metzdorf, Kristin, et al.
Publicado: (2023)

Fibroblasts are a site of murine cytomegalovirus lytic replication and Stat1-dependent latent persistence in vivo
por: Sitnik, Katarzyna M., et al.
Publicado: (2023)

IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection
por: Popovic, Branka, et al.
Publicado: (2017)

Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20
por: Charpak-Amikam, Yoav, et al.
Publicado: (2017)

Cytomegalovirus Infection Impairs Immune Responses and Accentuates T-cell Pool Changes Observed in Mice with Aging
por: Cicin-Sain, Luka, et al.
Publicado: (2012)

Life-long control of cytomegalovirus (CMV) by T resident memory cells in the adipose tissue results in inflammation and hyperglycemia
por: Contreras, Nico A., et al.
Publicado: (2019)

Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward
por: Olbrich, Laura, et al.
Publicado: (2021)

Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging
por: Nikolich-Žugich, Janko, et al.
Publicado: (2020)

Block of Death-Receptor Apoptosis Protects Mouse Cytomegalovirus from Macrophages and Is a Determinant of Virulence in Immunodeficient Hosts
por: Ebermann, Linda, et al.
Publicado: (2012)

The M25 gene products are critical for the cytopathic effect of mouse cytomegalovirus
por: Kutle, Ivana, et al.
Publicado: (2017)

A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
por: Tsuda, Yoshimi, et al.
Publicado: (2011)

A new reporter mouse cytomegalovirus reveals maintained immediate-early gene expression but poor virus replication in cycling liver sinusoidal endothelial cells
por: Dag, Franziska, et al.
Publicado: (2013)

Post-vaccination T cell immunity to omicron
por: Jacobsen, Henning, et al.
Publicado: (2022)

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns
por: Abassi, Leila, et al.
Publicado: (2023)

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies
por: Pommerenke, Claudia, et al.
Publicado: (2021)

A Novel Triple-Fluorescent HCMV Strain Reveals Gene Expression Dynamics and Anti-Herpesviral Drug Mechanisms
por: Rand, Ulfert, et al.
Publicado: (2021)

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy
por: Khorenko, Mikhail, et al.
Publicado: (2022)

UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2017)

Tcf1(+) cells are required to maintain the inflationary T cell pool upon MCMV infection
por: Welten, Suzanne P. M., et al.
Publicado: (2020)

The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose
por: Redeker, Anke, et al.
Publicado: (2018)

Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency
por: Dağ, Franziska, et al.
Publicado: (2014)

The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages
por: Thiel, Nadine, et al.
Publicado: (2016)

Resistance Against Cassava Brown Streak Viruses From Africa in Cassava Germplasm From South America
por: Sheat, Samar, et al.
Publicado: (2019)

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study
por: Brlić, Paola Kučan, et al.
Publicado: (2022)

Integrated coastal and ocean management : concepts and practices
por: Cicin-Sain, Biliana
Publicado: (1998)

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
por: Veleanu, Andrei, et al.
Publicado: (2022)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
por: Bertoglio, Federico, et al.
Publicado: (2021)

Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape
por: Lepiller, Quentin, et al.
Publicado: (2011)

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
por: Bertoglio, Federico, et al.
Publicado: (2021)

Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
por: Müller, Thomas R., et al.
Publicado: (2021)

Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
por: Jacobsen, Henning, et al.
Publicado: (2022)

Modeling coronavirus spike protein dynamics: implications for immunogenicity and immune escape
por: Kunkel, Genevieve, et al.
Publicado: (2021)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

The effect of chronic fluoxetine administration on anxiety-like behavior and expression of 5-HT-related proteins in rats with constitutively altered 5-HT homeostasis
por: Kesić, Maja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mj73gmv7jbnktt9brb7batmkj1